InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Taveras Arthur, Directeur scientifique. Officer active across 1 company, notably X4 Pharmaceuticals, Inc. Cumulatively, 9 reports have been logged. Split: 0 buy · 5 sells. Total volume traded: €73k. History available since 11 February 2022. The latest transaction was disclosed on 4 October 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Taveras Arthur is Chief Scientific Officer at X4 Pharmaceuticals, Inc (XNAS). He has 9 filings in total, and in the 9 sampled filings the recorded transactions run from 2022-02-14 to 2024-10-08, with EUR 0 in buys and EUR 73063 in sells, and the most frequent transaction nature being sale.